Abstract
Abstract Nanoparticle drug delivery systems have been used in the clinic since the early 1990's. Since that time, the field of nanomedicine has evolved alongside growing technological needs to improve the delivery of various therapeutics. Over these past decades, newer generations of nanoparticles have emerged that are capable of performing additional delivery functions that can enable treatment via new therapeutic modalities. In the current clinical landscape, many of these new generation nanoparticles have reached clinical trials and have been approved for various indications. In the first issue of Bioengineering & Translational Medicine in 2016, we reviewed the history, current clinical landscape, and clinical challenges of nanoparticle delivery systems. Here, we provide a 3 year update on the current clinical landscape of nanoparticle drug delivery systems and highlight newly approved nanomedicines, provide a status update on previous clinical trials, and highlight new technologies that have recently entered the clinic.
Keywords
NanomedicineClinical trialMedicineDrug deliveryModalitiesMedical physicsNanotechnologyNanoparticlePathology
Affiliated Institutions
Related Publications
Progress and challenges towards targeted delivery of cancer therapeutics
Targeted delivery approaches for cancer therapeutics have shown a steep rise over the past few decades. However, compared to the plethora of successful pre-clinical studies, onl...
Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
The use of nanotechnology in medicine has the potential to have a major impact on human health for the prevention, diagnosis, and treatment of diseases. One particular aspect of...
BioTM Buzz (Volume 4, Issue 1)
In this Special Issue of Bioengineering & Translational Medicine, we honor two luminaries in the AIChE community who pioneered the field of drug delivery and biomaterials, Profe...
Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement
Lipid nanoparticles (LNPs) have emerged across the pharmaceutical industry as promising vehicles to deliver a variety of therapeutics. Currently in the spotlight as vital compon...
Nanoparticles in Medicine: Therapeutic Applications and Developments
Nanotechnology is the understanding and control of matter generally in the 1-100 nm dimension range. The application of nanotechnology to medicine, known as nanomedicine, concer...
Publication Info
- Year
- 2019
- Type
- review
- Volume
- 4
- Issue
- 3
- Pages
- e10143-e10143
- Citations
- 1551
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
1551
OpenAlex
27
Influential
Cite This
Aaron C. Anselmo,
Samir Mitragotri
(2019).
Nanoparticles in the clinic: An update.
Bioengineering & Translational Medicine
, 4
(3)
, e10143-e10143.
https://doi.org/10.1002/btm2.10143
Identifiers
- DOI
- 10.1002/btm2.10143
- PMID
- 31572799
- PMCID
- PMC6764803